Stockreport

HUTCHMED (China) Ltd (HCM) (Q4 2024) Earnings Call Highlights: Achieving Profitability and ... [Yahoo! Finance]

HUTCHMED (China) Limited - American Depositary Shares  (HCM) 
NASDAQ:AMEX Investor Relations: chi-med.com/investors/information-for-shareholders
PDF Net Income: $37 million. Oncology Business Revenue: Over $360 million. Cash Resources: Over $830 million, a reduction of around $50 million from 2023. 2025 Oncolo [Read more]